Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
The patients date of birth
The decision to push VK2735 into late-stage studies follows promising findings from the Phase II VENTURE study, which showed that the candidate could safely and substantially reduce body weight in overweight or obese patients with at least one related comorbidity
The report analyzed freight data from April and May, 2025 looking for suspect shipments of active pharmaceutical ingredients used to make medications
Novo is down 19% this year on worries that the company is rapidly losing market share to American pharmaceutical rival Eli Lilly
US$ 29.74
US$ 25.85
US$ 28.83
US$ 24.00
US$ 21.51
US$ 26.26
US$ 22.76
US$ 24.28
